WG Biotech ApS
Director at Y-mAbs Therapeutics, Inc.
- Sold, on record
- $10.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 1, 2021 2021
Sold 31,864 shares at $36.17 ($1.2M)
WG Biotech ApS, 10% owner
Sold 0.7% of holdings ($162M position)4.4M shares leftFirst sale on recordFiling
- 2 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 4, 2021 +3 days
Sold 34,507 shares at $33.28 ($1.1M)
WG Biotech ApS, 10% owner
Sold 0.8% of holdings ($148M position)4.4M shares leftFiling
- 3 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 7, 2021 +3 days
Sold 72,400 shares at $34.15 ($2.5M)
WG Biotech ApS, 10% owner
Sold 1.6% of holdings ($151M position)4.3M shares leftFiling
- 4 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualJun 9, 2021 +2 days
Sold 150,000 shares at $35.99 ($5.4M)
WG Biotech ApS, Director
Sold 3.5% of holdings ($156M position)4.2M shares left4.3x usual sizeFiling
- 5 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 10, 2021 +1 day
Sold 11,229 shares at $36.15 ($406k)
WG Biotech ApS, Director
Sold 0.3% of holdings ($151M position)4.2M shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | Jun 11, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 11,229 | $406k | 0.3% | Plan not stated | SEC |
| Jun 9, 2021 | Jun 10, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 150,000 | $5.4M | 3.5% | Unusual | SEC |
| Jun 7, 2021 | Jun 9, 2021 | Y-mAbs Therapeutics, Inc. | 10% owner | Form 4 sale | 72,400 | $2.5M | 1.6% | Plan not stated | SEC |
| Jun 4, 2021 | Jun 7, 2021 | Y-mAbs Therapeutics, Inc. | 10% owner | Form 4 sale | 34,507 | $1.1M | 0.8% | Plan not stated | SEC |
| Jun 1, 2021 | Jun 2, 2021 | Y-mAbs Therapeutics, Inc. | 10% owner | Form 4 sale | 31,864 | $1.2M | 0.7% | Plan not stated | SEC |